Since it was noted that GEM treatment could increase the expression of PD-1 and PD-L1 (30, 31), accumulating evidence has shown that GEM + ICIs exert synergistic effects against cancer cells compared with monotherapy and conquer resistance to anti-immune checkpoint therapy (32, 33). Here, PDCD1 is linked to cancer.